Verona Pharma (NASDAQ:VRNA) Given New $36.00 Price Target at HC Wainwright
Verona Pharma (NASDAQ:VRNA – Get Free Report) had its price target boosted by equities researchers at HC Wainwright from $32.00 to $36.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s target price points to a potential upside of 148.96% from […]
More Stories
Archer Investment Corp Acquires 567 Shares of Phillips 66 (NYSE:PSX)
Archer Investment Corp raised its stake in Phillips 66 (NYSE:PSX – Free Report) by 56.4% in the third quarter, Holdings...
Coterra Energy (NYSE:CTRA) Price Target Raised to $35.00
Coterra Energy (NYSE:CTRA – Free Report) had its target price hoisted by UBS Group from $31.00 to $35.00 in a...
Walt Disney (NYSE:DIS) Given New $110.00 Price Target at Macquarie
Walt Disney (NYSE:DIS – Free Report) had its target price upped by Macquarie from $91.00 to $110.00 in a research...
Heritage Investment Group Inc. Acquires 143 Shares of Invesco QQQ (NASDAQ:QQQ)
Heritage Investment Group Inc. raised its position in Invesco QQQ (NASDAQ:QQQ – Free Report) by 16.7% during the 3rd quarter,...
Cisco Systems Reports First Quarter Earnings
On November 13, 2024, technology giant Cisco Systems, Inc. released its financial results for the fiscal first quarter of 2025,...
China Literature Limited (OTCMKTS:CHLLF) Short Interest Update
China Literature Limited (OTCMKTS:CHLLF – Get Free Report) saw a large increase in short interest in the month of October....